169169 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types Cells of the immune system
Improved monocyte activation test
#2MICROFLUIDIC CHIP AND METHODS FOR CULTURING SINGLE CELLS AND SCREENING AND EXPORTING CELL POPULATIONS
#3METHODS AND COMPOSITIONS FOR IDENTIFYING EPITOPES
#4COMPETITIVE LIGAND BINDING ASSAYS
#5COMBINED INVASTION AND CYTOTOXICITY ASSAY USING CHEMOKINE SECRETING TARGET CELLS
#6METHODS TO PRESERVE TUMOR-STROMAL INTERACTIONS IN CULTURE AND THERAPEUTIC PREDICTIVE APPLICATIONS THEREOF
#7MULTI-ORGAN MICROFLUIDIC CHIP
#8CELL MEDIATED IMMUNE RESPONSE ASSAY
#9PEPTIDE COMPOSITION AND USES THEREOF
#10LYMPHOCYTE STIMULATION ASSAY TO QUANTIFY IMMUNE RESPONSES
#11METHODS AND COMPOSITIONS FOR TREATING CANCERS BY MODULATING THE EXPRESSION AND/OR ACTIVITY OF STUB1
#12ANTI-FCRN ANTIBODIES
#13INTRACELLULAR KINASE ASSOCIATED WITH RESISTANCE AGAINST ANTI-TUMOUR IMMUNE RESPONSES, AND USES THEREOF
#14FLUOROMETRIC METHODS FOR DETECTION OF ALLERGIC SENSITIVITY TO ENVIRONMENTAL, FOODSTUFF, AND MEDICAMENT STIMULANTS
#15METHODS FOR IDENTIFYING AND TREATING DISEASES
#16METHODS FOR PERFORMING MINIATURIZED DYNAMIC ASSAYS USING MICROFLUIDICS AND RELATED SYSTEMS
#17Patient-Derived Ex-Vivo Tumor Tissue Model
#18METHOD FOR EVALUATING QUALITY OF INDUCEMENT INHIBITORY-T-CELL FORMULATION
#19METHODS FOR PERFORMING MINIATURIZED DYNAMIC ASSAYS USING MICROFLUIDICS AND RELATED SYSTEMS
#20ASSEMBLED GLYCOPROTEINS
#21METHOD FOR DETERMINING THE ACTIVITY OF A DRUG OR DRUG CANDIDATE UNDER CONDITIONS OF MICROGRAVITY
#22NLRP3 Variants & Library Screen for NLRP3 Inhibitors with the Same
#23Cultured Thymus Tissue Transplantation Promotes Donor-Specific Tolerance to Allogeneic Solid Organ Transplants
#24IMMUNITY DETECTING KIT AND USING METHOD THEREOF
#25METHOD FOR PREDICTING GENE TRANSFER RATE
#26ASSAY METHODS AND USES THEREOF FOR SCREENING ALZHEIMER'S DISEASE TREATMENT COMPOUNDS
#27TREATMENT FOR INFLAMMATORY DISEASE
#28COMPOSITIONS AND METHODS FOR USING FIXED BIOLOGICAL SAMPLES IN PARTITION-BASED ASSAYS
#29METHOD FOR EXPANSION AND MAINTENANCE OF NK CELLS FOR IMMUNOTHERAPY
#30IMMUNE CELL POPULATIONS AND USES THEREOF
#31METHODS AND COMPOSITIONS FOR PERTURBING MONOCYTE AND NEUTROPHIL LINEAGES
#32METHOD AND SYSTEM FOR MEASURING CELL-MEDIATED IMMUNITY TO ADENO-ASSOCIATED-VIRUS INFECTION
#33ASSAY METHODS FOR SCREENING INHIBITORS OF SICKLE CELL DISEASE, ß-THALASSEMIA, OR SICKLE CELL ß-THALASSEMIA, OR A PHENOTYPE THEREOF
#34MonoMac-1 Cells Expressing CD16 and CD163
#35COMPOSITIONS AND METHODS FOR DETECTING PROSTATE CANCER
#36PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMC) PHENOTYPES AS BIOMARKERS FOR PATIENTS WITH ALZHEIMER'S DISEASE AND/OR MILD COGNITIVE IMPAIRMENT (MCI)
#37METHODS AND COMPOSITIONS FOR IDENTIFYING EPITOPES
#38METHOD OF EVALUATING IMMUNE RESPONSE OF CELL GROUP TO TEST SUBSTANCE
#39METHOD OF EVALUATING IMMUNE RESPONSE OF CELL GROUP TO TEST SUBSTANCE
#40PHYSIOLOGY AND PATHOPHYSIOLOGY OF HUMAN GUT: INTESTINE-ON-CHIP
#41COMPOUNDS AND METHODS FOR TREATMENT OF DIAMOND BLACKFAN ANEMIA
#42BIOMARKERS PREDICTIVE OF CYTOKINE RELEASE SYNDROME
#43METHODS OF MEASURING PROTEIN LEVELS OF CELLS AND USES THEREOF
#44DIAGNOSTIC
#45METHODS FOR ASSIGNING A PHENOTYPIC SIGNATURE FOR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
#46METHOD FOR SCREENING POTENTIAL THERAPEUTIC AGENTS
#47METHODS OF DETECTING SIGNATURES OF DISEASE OR CONDITIONS IN BODILY FLUIDS
#48METHOD FOR INDUCING AND DETECTING SOLUBLE LOX-1 (sLOX-1) IN CULTURED BLOOD CLOTS
#49ARTICLES OF MANUFACTURE AND METHODS RELATED TO TOXICITY ASSOCIATED WITH CELL THERAPY
#50ASSAY
#51New Treatment of Sepsis
#52METHOD FOR SCREENING POTENTIAL THERAPEUTIC AGENTS
#53Compositions and methods for using fixed biological samples
#54POOLS OF MICROBIAL PROTEIN FRAGMENTS
#55RHEOLOGICALLY BIOMIMETIC FLUID SURROGATE
#56TISSUE ORGANOID BIOPRINTING AND HIGH-THROUGHPUT SCREENING METHODOLOGY
#57OBTAINING INFORMATION FROM A BIOLOGICAL SAMPLE IN A FLOW CELL
#58METHOD FOR ASSESSING THE OPSONOPHAGOCYTOTIC CAPACITY OR TROGOCYTOTIC CAPACITY OF AN ANTIGEN-BINDING MOLECULE
#59CHIMERIC RECEPTOR POLYPEPTIDE AND METHODS OF ACTIVATION THEREOF
#60GENETICALLY MODIFIED HUMAN NATURAL KILLER CELL LINES
#61De-immunized factor VIII molecule and pharmaceutical compositions comprising the same
#62APPLICATION OF STEM-CELL DERIVED MONOCYTES IN A MONOCYTE ACTIVATION TEST (MAT) FOR THE ASSESSMENT OF PYROGENICITY AND INFLAMMATORY POTENTIAL
#63FLOW BASED ASSAYS FOR THERAPEUTICS
#64Portable Closed System for Culturing Cells Using Small Volumes of Capillary Blood
#65Structure-Function Relationships in the Development of Immunotherapeutic Agents
#66GENETICALLY MODIFIED HUMAN NATURAL KILLER CELL LINES
#67METHOD FOR DETERMINATION OF BASOPHIL ACTIVATION AND KITS THEREFORE
#68BAT ASSAYS FOR IN VITRO DETERMINATION OF ALLERGIC REACTION
#69TEST METHOD, OF DIVIDING BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN) INTO SUBTYPES
#70HUMAN INNATE LYMPHOID CELL PRECURSORS: IDENTIFICATION, CHARACTERIZATION, APPLICATIONS
#71Method for determining susceptibility to SARS-CoV-2 infection
#72METHOD FOR SELECTING CANCER TREATMENT REGIMEN
#73EFFICIENT GENOME EDITING IN PRIMARY MYELOID CELLS
#74METHOD FOR INDUCING EXTRACELLULAR TRAP (ET) FORMATION
#75METHOD AND SYSTEM FOR DETECTING CELL-KILLING EFFICACY AND/OR IMMUNE ACTIVITY, AND APPLICATION THEREOF
#76COMPOSITIONS AND METHODS FOR TREATMENT
#77Methods for predicting response to treatment
#78CELLS FOR TREATING CANCER
#79T CELL-BASED METHODS FOR PREDICTING POLYPEPTIDE IMMUNOGENICITY
#80CYTOKINE DERIVED TREATMENT WITH REDUCED VASCULAR LEAK SYNDROME
#81METHODS FOR DIAGNOSING IMMEDIATE HYPERSENSITIVY REACTION
#82CELL-BASED METHODS FOR PREDICTING POLYPEPTIDE IMMUNOGENICITY
#83Physiology and pathophysiology of human gut: intestine-on-chip
#84METHOD OF DETERMINING PERCENTAGE OF IMMUNE CELL TYPES IN A SALIVA SPECIMEN
#85HUMAN T-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA CELL STRAIN AND USE THEREOF
#86Anti-FcRn Antibodies
#87DIAGNOSTICS
#88Methods of Screening to Determine Effective Dosing of Cancer Therapeutics
#89AN IN VITRO KIT AND A METHOD FOR DIAGNOSTICS IN TRANSPLANTS AND/OR AUTOIMMUNE DISEASES AND/OR TUMOR DISEASES AND/OR VACCINATIONS AND A MESSENGER-SUBSTANCE-CONTAINING SUPERNATANT, CELL-CONTAINING SEDIMENT, AND A COMBINATION, FOR USE IN DIAGNOSTICS IN TRANSPLANTS AND/OR AUTOIMMUNE DISEASES AND/OR TUMOR DISEASES AND/OR VACCINATIONS
#90ASSAY FOR RAPID EVALUATION OF CHOROIDAL MAST CELL DEGRANULATION
#91Product and methods useful for modulating and evaluating immune responses
#92T-CELL RECEPTOR NEOANTIGEN INTERACTION ANALYSIS VIA MICROFLUIDICS
#93Micro-fluidic devices for assaying biological activity
#94SYSTEMS AND METHODS FOR EVALUATING NK CELLS
#95COMPOSITION FOR DETERMINATION OF CELL-MEDIATED IMMUNE RESPONSIVENESS
#96HIGH-CONTENT ANALYSIS METHOD
#97Microfluidic Devices and Methods for Use Thereof in Multicellular Assays of Secretion
#98IN VITRO METHOD FOR OBTAINING CLINICAL DATA IN PATIENTS SUFFERING FROM AN INFLAMMATORY DISEASE
#99METHODS FOR DIAGNOSIS, PROGNOSIS, AND TREATMENT OF CANCER
#100ASSAY FOR IMMUNE CELL RECOVERY
#101Method for predicting and monitoring clinical response to immunomodulatory therapy
#102METHODS AND PRODUCTS FOR TREATMENT OF GASTROINTESTINAL DISORDERS
#103ANTI-CD53 COMPOSITIONS AND METHODS FOR MODULATING MYELOID CELL INFLAMMATORY PHENOTYPES AND USES THEREOF
#104PDL1 POSITIVE NK CELL CANCER TREATMENT
#105TREATMENT METHODS
#106MURINE MODEL OF FETAL/NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
#107BIOMARKER FOR RHEUMATOID ARTHRITIS TREATMENT
#108METHODS OF USING IL-21 FOR ADOPTIVE IMMUNOTHERAPY AND IDENTIFICATION OF TUMOR ANTIGENS
#109IDENTIFICATION AND USE OF NOVOPEPTIDES FOR THE TREATMENT OF CANCER
#110POROUS HOLLOW FIBER MEMBRANE AND METHODS OF USING IT TO SELECT IMMUNE CHECKPOINT INHIBITOR
#111Biomarkers for CNS Disease Modification
#112Method for recovering two or more genes, or gene products, encoding an immunoreceptor
#113FOXM1-DERIVED PEPTIDE, AND VACCINE INCLUDING SAME
#114METHODS FOR IDENTIFYING BETA-GLUCAN BINDING TO IMMUNE CELLS
#115Cultured thymus tissue transplantation promotes donor-specific tolerance to allogeneic solid organ transplants
#116METHODS FOR IMPROVED IMMUNOTHERAPY
#117PATIENT SPECIFIC CLINICAL TRIALS AND ASSOCIATED METHODS OF TREATMENT
#118DELIVERY OF BIOMOLECULES TO IMMUNE CELLS
#119METHODS TO PRESERVE TUMOR-STROMAL INTERACTIONS IN CULTURE AND THERAPEUTIC PREDICTIVE APPLICATIONS THEREOF
#120ANALYTICAL METHODS AND ARRAYS FOR USE IN THE SAME
#121METHODS AND COMPOSITIONS RELATED TO TARGETING FFAR2 AND ILC3 POPULATIONS FOR THE TREATMENT OF A GASTROINTESTINAL DISEASE
#122MEANS AND METHODS FOR DETERMINING METABOLIC ADAPTATION
#123Obtaining information from a biological sample in a flow cell
#124Microfluidic device and diagnostic methods for allergy testing based on detection of basophil activation
#125Use of mesenchymal stem cells for the treatment of inflammation
#126Compositions and methods for using cross-dressing to enhance anti-tumor immune responses
#127MSC prediction algorithm
#128PEPTIDE COMPOSITION AND USES THEREOF
#129METHODS FOR DYNAMIC MODELING AND CLOSED-LOOP CONTROL OF INFLAMMATION
#130METHODS OF TREATING AND PREVENTING STAPHYLOCOCCUS AUREUS INFECTIONS AND ASSOCIATED CONDITIONS
#131COMBINED INVASION AND CYTOTOXICITY ASSAY USING CHEMOKINE SECRETING TARGET CELLS
#132DECREASING IMMUNE ACTIVITY THROUGH MODULATION OF POSTCELLULAR SIGNALING FACTORS
#133METHOD FOR EVALUATING ANTI-INFECTIVE DRUGS, VACCINES, ETC. USING IMMORTALIZED MONOCYTIC CELLS AND INDUCED CELLS
#134IMMUNOGLOBULIN CONSTANT REGION FC RECEPTOR BINDING AGENTS
#135METHOD FOR ANALYZING IMMUNE CELLS
#136DIRECT MEASUREMENT OF IMMUNE SYSTEM RADIOSENSITIVITY AND RADIOTHERAPY TREATMENT PLAN OPTIMIZATION
#137INCREASING IMMUNE ACTIVITY THROUGH MODULATION OF POSTCELLULAR SIGNALING FACTORS
#138Biomarkers for predicting responsiveness to decitabine therapy
#139METHODS OF DETECTING SIGNATURES OF DISEASE OR CONDITIONS IN BODILY FLUIDS
#140TELOMERASE HOLOENZYME COMPLEX AND METHODS OF USE THEREOF
#141CCL24 as a diagnostic and therapeutic target for breast cancer
#142Methods for generating barcoded nucleic acid molecules using fixed cells
#143ANALYTICAL METHODS AND ARRAYS FOR USE IN THE SAME
#144DENDRITIC CELL RECRUITMENT FROM BLOOD TO BRAIN IN NEURODEGENERATIVE DISEASE
#145Murine model of fetal/neonatal alloimmune thrombocytopenia
#146Obtaining information from a biological sample in a flow cell
#147Human innate lymphoid cell precursors: identification, characterization, applications
#148Unipotent Neutrophil Progenitor Cells, Methods of Preparation, and Uses Thereof
#1493D SPATIALLY PATTERNED LYMPH NODE ON A MICROFLUIDIC DEVICE
#150Cell-substrate impedance monitoring of cancer cells
#151INTRACELLULAR KINASE ASSOCIATED WITH RESISTANCE AGAINST ANTI-TUMOUR IMMUNE RESPONSES, AND USES THEREOF
#152DENDRITIC CELL IMMUNORECEPTOR AGONIST
#153PATIENT-SPECIFIC CANCER THERAPY SCREENING AND METHODS OF TREATMENT
#154In vitro immune synapse system and method of in vitro evaluating immune response using the same
#155Methods of producing patient-specific anti-cancer therapeutics and methods of treatment therefor
#156BIOLUMINESCENT SCREENING TEST FOR DETECTING CELL CYTOLYSIS
#157MODIFIED NATURAL KILLER CELLS AND NATURAL KILLER CELL LINES TARGETTING TUMOUR CELLS
#158Methods of treating and preventing infections and associated conditions
#159MODULATION OF SPLENOCYTES IN CELL THERAPY
#160Antigen screening system
#161Structure-Function Relationships in the Development of Immunotherapeutic Agents
#162Microfluidic Devices and Methods for Use Thereof in Multicellular Assays of Secretion
#163Competitive Ligand Binding Assays
#164Rheologically biomimetic fluid surrogate
#165Cell chemotaxis assays
#166TLR agonist-enhanced in vitro assay of cell mediated immune responsiveness
#167METHODS AND KITS FOR DIAGNOSIS OF FAMILIAL MEDITERRANEAN FEVER
#168Devices and methods related to airway inflammation
#169Methods for predicting response to treatment
#170Flow based assays for therapeutics
#171A METHOD FOR DETERMINING MYELOID NATURAL KILLER (NK)-CELLS AND USE THEREOF
#172DOSE DETERMINATION FOR IMMUNOTHERAPEUTIC AGENTS
#173IN VITRO IMMUNE SYNAPSE SYSTEM AND METHOD OF IN VITRO EVALUATING IMMUNE RESPONSE USING THE SAME
#174Compounds and methods for treatment of Diamond Blackfan anemia
#175METHODS AND COMPOSITIONS FOR MODULATING INNATE LYMPHOID CELL PATHOGENIC EFFECTORS
#176Cell mediated immune response assay
#177PROTEOGLYCAN IRREGULARITIES IN ABNORMAL FIBROBLASTS AND THERAPIES BASED THEREFROM
#178ANALYTICAL METHODS AND ARRAYS FOR USE IN THE SAME
#179Articles of manufacture and methods related to toxicity associated with cell therapy
#180Methods and compositions for identifying epitopes
#181Agents that modulate immune cell activation and methods of use thereof
#182USE OF PEPTIDES AS BIOMARKERS IN THE DIAGNOSIS, CONFIRMATION AND TREATMENT OF A NEUROLOGICAL DISORDER AND TCR AND/OR HLA IMMUNOPROFILING IN NEURODEGENERATIVE DISEASE
#183Micro-fluidic devices for assaying biological activity
#184Hypoxic NK cells and methods therefor
#185Peptides that block leukocyte recruitment and methods of use
#186ASSAY FOR PHAGOCYTIC IMMUNE CELL DEFECTS ASSOCIATED WITH AUTISM
#187MonoMac-1 cells expressing CD16 and CD163
#188METHODS AND KITS FOR DETECTING BASOPHIL ACTIVATION
#189FLOW CYTOMETRY ASSAY METHODS
#190PHARMACEUTICAL COMBINATIONS FOR IMMUNOTHERAPY
#191Methods of using IL-21 for adoptive immunotherapy and identification of tumor antigens
#192CXR4 as a susceptibility locus in juvenile idiopathic arthritis (JIA) and methods of use thereof for the treatment and diagnosis of the same
#193Method for preparing multimeric forms of the hepatitis c virus (HCV) envelope glycoprotein 2 (HCV E2)
#194METHODS AND KITS FOR ANALYSING THE STEADY-STATE ACTIVATION OR INHIBITION OF ITAM SIGNALLING OF IMMUNORECEPTORS IN BLOOD LEUKOCYTES
#195ADAPTIVE CHIMERIC ANTIGEN RECEPTOR T-CELL DESIGN
#196Cultured thymus tissue transplantation promotes donor-specific tolerance to allogeneic solid organ transplants
#197Process for carrying out an allergy test, process for determining degranulation in cells, device for carrying out an allergy test and microfluidic chip
#198Anti-FcRn antibodies
#199NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST ATTENUATES ILC2-DEPENDENT AIRWAY HYPERREACTIVITY
#200COMPOSITION FOR EVALUATING IMMUNE RESPONSE INDUCING ABILITY OF DRUG
#201Immunoglobulin constant region Fc receptor binding agents
#202METHODS FOR IDENTIFYING AND MODULATING IMMUNE PHENOTYPES
#203Methods of treating and preventing infections and associated conditions
#204Multiplexed immune cell assays on a micropillar/microwell chip platform
#205Compositions and methods for evaluating and modulating immune responses by detecting and targeting GATA3
#206Compositions and methods for evaluating and modulating immune responses by detecting and targeting POU2AF1
#207CELL OBSERVATION DEVICE, METHOD FOR EVALUATING ACTIVITY LEVEL OF IMMUNE CELLS, AND METHOD FOR CONTROLLING QUALITY OF IMMUNE CELLS
#208Infiltrating immune cell proportions predict anti-TNF response in colon biopsies
#2093-D TISSUE CULTURE BASED METHOD TO ASSESS MITOCHONDRIAL IMPAIRMENT
#210In vitro assays for inhibition of microglial activation
#211Method for determining the cell mediated immune competence of a subject
#212Method for detecting basophil activation
#213Anti-cancer drug assessment method
#214Methods for treating an infectious or neoplastic disease
#215Compositions for and methods of identifying antigens
#216Method for predicting and monitoring clinical response to immunomodulatory therapy
#217Antigen screening system
#218Membrane for reconstructed tissue comprising pores of several diameters
#219SELECTIVELY SUBSTITUTED QUINOLINE COMPOUNDS
#220Systems And Methods For Determining The Risk Of Severe Allergic Reaction To Allergen, And The Immunological Protection Afforded By Vaccines
#221INTERCELLULAR LABELING OF LIGAND-RECEPTOR INTERACTIONS
#222FOXM1-derived peptide, and vaccine including same
#223CONSTRUCTION METHOD OF CELL MODELS FOR DETECTING PYROGENS, CELL MODELS AND PYROGEN DETECTION KITS
#224Chip for detecting allergy, manufacturing method thereof and a method for detecting allergy using therefor
#225DETERMINATION OF FAVORABLE DATE(S) FOR THERAPEUTIC TREATMENT DELIVERY
#226Micro-fluidic devices for assaying biological activity
#227COMPOSITION FOR DETERMINATION OF CELL-MEDIATED IMMUNE RESPONSIVENESS
#228Biomarkers predictive of cytokine release syndrome
#229Modulation of splenocytes in cell therapy
#230METHODS FOR DETERMINING DRUG EFFICACY USING CEREBLON-ASSOCIATED PROTEINS
#231Immunoglobulin constant region Fc receptor binding agents
#232Allogeneic autophagosome-enriched composition for the treatment of disease
#233Allogeneic autophagosome-enriched composition for the treatment of disease
#234CANCER THERAPY TARGETING TETRASPANIN 33 (TSPAN33) IN MYELOID DERIVED SUPPRESSOR CELLS
#235Delivery of biomolecules to immune cells
#236Method for Hematology Analysis
#237Methods of detecting signatures of disease or conditions in bodily fluids
#238MOLECULAR DELIVERY WITH NANOWIRES
#239Methods to preserve tumor-stromal interactions in culture and therapeutic predictive applications thereof
#240METHODS AND COMPOSITIONS FOR USING MHC CLASS II INVARIANT CHAIN POLYPEPTIDES AS A RECEPTOR FOR MACROPHAGE MIGRATION INHIBITORY FACTOR
#241MHC-independent tumor-associated antigens
#242Eukaryotic expression vectors comprising regulatory elements of the globin gene clusters
#243Methods and compositions for affecting immunological responsiveness
#244Methods of treating and preventing infections and associated conditions
#245Selectively substituted quinoline compounds
#246Liquid formulation of long acting insulinotropic peptide conjugate
#247One step phagocytosis-cell activation-cell death assay
#248Therapeutic use for αproteinase inhibitor in hematopoiesis
#249Compositions and methods for preventing and treating infection
#250Biomarkers for predicting responsiveness to decitabine therapy
#251Methods For Screening Therapeutic Compounds
#252In vivo methods for identifying cancer-associated immunotherapy targets
#253Identification and use of novopeptides for the treatment of cancer
#254Antibodies that specifically bind to TIM3
#255Method of identifying risk for thyroid disorder
#256Biosensor system for the rapid detection of analytes
#257Biosensor system for the rapid detection of analytes
#258Biosensor system for the rapid detection of analytes
#259METHODS AND COMPOSITIONS FOR SYSTEMIC LUPUS ERYTHEMATOSUS
#260Inflammation-targeted neutrophil granulocyte drug delivery system and use thereof
#261Analytical Methods and Arrays for Use in the Same
#262Analytical Methods and Arrays for Use in the Same
#263METHOD FOR ENHANCING IMMUNE CELL FUNCTION AND METHOD FOR ASSESSING IMMUNE CELL MULTIFUNCTIONALITY
#264Methods of producing patient-specific anti-cancer therapeutics and methods of treatment therefor
#265Probiotic and new biomarker
#266Methods and compositions for T cell generation and uses thereof
#267METHOD FOR ENHANCING IMMUNE CELL FUNCTION AND METHOD FOR ASSESSING IMMUNE CELL MULTIFUNCTIONALITY
#268Immunoglobulin constant region Fc receptor binding agents
#269METHOD AND ENZYME SOLUTION FOR FLOW-CYTOMETRIC DETECTION OF LIGHT CHAIN RESTRICTION
#270PHARMACEUTICAL COMBINATIONS FOR IMMUNOTHERAPY
#271Diagnostic of chronic myelomonocytic leukemia (CMML) by flow cytometry
#272Diagnostics
#273Dendritic cell immune receptor activator, method for activating dendritic cell immune receptor, osteoclast formation inhibitor, method for inhibiting osteoclast formation, dendritic cell differentiation/proliferation inhibitor, method for inhibiting dendritic cell differentiation/proliferation, cytokine production inhibitor, method for inhibiting cytokine production, therapeutic method and screening method
#274Methods for treating an infectious or neoplastic disease
#275TREATMENT OF MULTIPLE SCLEROSIS BY INHIBITION OF ALLOGRAFT INFLAMMATORY FACTOR-1
#276PEPTIDES THAT BLOCK LEUKOCYTE RECRUITMENT AND METHODS OF USE
#277Methods of detecting signatures of disease or conditions in bodily fluids
#278Method for recovering two or more genes, or gene products, encoding an immunoreceptor
#279Methods for detecting contaminants in solutions containing glucose polymers
#280Apparatus for screening cells
#281VACCINE COMPRISING AMB A 1 PEPTIDES FOR USE IN THE TREATMENT OF RAGWEED ALLERGY
#282Methods of treating and preventing infections and associated conditions
#283Diagnostic and immunotherapy compositions and methods for disease states mediated by inhibitor-resistant CD8 T-cells
#284Method for evaluation of function of phagocyte
#285Methods of detecting signatures of disease or conditions in bodily fluids
#286Immunoglobulin constant region Fc receptor binding agents
#287CXCR4 as a susceptibility locus in juvenile idiopathic arthritis (JIA) and methods of use thereof for the treatment and diagnosis of the same
#288SELECTIVELY SUBSTITUTED QUINOLINE COMPOUNDS
#289SKIN MODEL
#290MODULATION OF NKG2D
#291Composition comprising a cell sample from a subject with scoliosis and a reagent for detecting PTPμ or PIPK1y
#292Biosensor system for the rapid detection of analytes
#293MOLECULAR DELIVERY WITH NANOWIRES
#294Proteasome inhibition assay and methods of use
#295Methods for assessing cell viability or predicting cell response to a treatment using cell movement
#296Microfluidic devices and methods for use thereof in multicellular assays of secretion
#2973D ADCC NK FACS assay
#298METHODS AND COMPOSITIONS FOR SYSTEMIC LUPUS ERYTHEMATOSUS
#299Treatment of inflammatory skin disease
#300Cell chemotaxis assays